Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1992-3-4
|
pubmed:abstractText |
Recombinant interleukin-2 (rIL-2) is able to maintain the growth and multiplication of T-lymphocytes and IL-2 dependent CTLL-2 cells up to 28 days with the multiplication of T-lymphocytes as high as about 1000 fold. When rIL-2 and its monoclonal antibody were added together, the above functions of rIL-2 were specially blocked, showing that these biological functions were exerted specifically by rIL-2. The rIL-2 is also able to increase the natural killer (NK) activity up to 46-96%, while higher concentrations of rIL-2 might exhibit inhibitory effect. The cytotoxicity of lymphokine activated killer (LAK) cells induced by rIL-2 for killing HL-60 cell line and solid tumour (human lung carcinoma) reached 54.84% and 37.96%, respectively. All these results indicate that the biological functions of rIL-2 were quite similar to that of the natural one.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1042-749X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
7
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
25-31
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:1773013-Antibodies, Monoclonal,
pubmed-meshheading:1773013-Cell Division,
pubmed-meshheading:1773013-Cells, Cultured,
pubmed-meshheading:1773013-Humans,
pubmed-meshheading:1773013-Interleukin-2,
pubmed-meshheading:1773013-Killer Cells, Lymphokine-Activated,
pubmed-meshheading:1773013-Killer Cells, Natural,
pubmed-meshheading:1773013-Recombinant Proteins,
pubmed-meshheading:1773013-T-Lymphocytes,
pubmed-meshheading:1773013-Tumor Cells, Cultured
|
pubmed:year |
1991
|
pubmed:articleTitle |
Biological functions of recombinant human interleukin-2.
|
pubmed:affiliation |
Shanghai Institute of Biochemistry, Chinese Academy of Sciences.
|
pubmed:publicationType |
Journal Article
|